Breaking News

Abiomed to join S&P 500, stock slips after hours

Abiomed Inc. ABMD, -Zero.05% will sign up for the S&P 500 index SPX, -Zero.24% changing Wyndham Worldwide Corp. WYN, -Zero.58% S&P Dow Jones Indices stated overdue Friday. The Danvers, Mass. based totally clinical instrument corporate is anticipated to transport to the S&P 500 earlier than the opening of buying and selling on May 31 as it is extra consultant of the index than Wyndham, S&P stated. Shares of Abiomed declined 2.nine% after hours, following a zero.1% decline to close the common consultation at $394.28.